Harry Shapiro
Director DrugWise
Having done a brief round-up of 2016 in my first column, this week's column is a catch-up on the news so far in 2017.
Previously I mentioned the harm reduction battle cross-over between drugs and e-cigarettes: reports in the news this year highlight another connection – how scientists, clinicians and the media can mislead the general public.
Harry Shapiro
Director DrugWise
Welcome to my new column brought to you by Nicotine Science and Policy. The idea is that I provide a summary and commentary of the weeks' news and events for those who have not had the time to check out the NSP News Digest on a daily basis or missed an important news item from elsewhere.